| Evaluate Bioequivalence of Micafungin (50mg/Vial) (NCT05496725) | Yung Shin Pharm. Ind. Co., Ltd. | 2022-01-06 |
| Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (NCT04368559) | Mundipharma Research Limited | 2020-05-11 |
| Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis (NCT04225195) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-01-01 |
| Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin (NCT03906916) | Fadoi Foundation, Italy | 2018-07-18 |
| Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (NCT03059992) | Scynexis, Inc. | 2017-04-01 |
| CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension (NCT02734862) | Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2016-07-26 |
| NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis (NCT02801682) | Medical University of Graz | 2016-06-01 |
| BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia (NCT02220790) | Duke University | 2015-01-01 |
| Non-Conventional Microbiological Methods in the Diagnosis of Candidemia (NCT07422155) | Institute of Oncology Ljubljana | 2015-01-01 |
| Variability of Fluconazole Concentration in Critically Ill Patients (NCT02491151) | University Medical Center Groningen | 2014-10-01 |
| Pharmacokinetics of Micafungin in Patients of Intensive Care Units (NCT02164890) | University Hospital, Limoges | 2014-06-01 |
| Genetic Susceptibility Factors for Candidemia. (NCT02841501) | University Hospital, Lille | 2013-06-01 |
| Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation (NCT01666769) | Kevin Watt | 2013-01-01 |
| Pharmacokinetics of Micafungin in Critically Ill Patients (NCT01716988) | University Medical Center Groningen | 2012-10-01 |
| Invasive Candidiasis in Saudi ICUs (NCT01490684) | Hasan Al-Dorzi | 2012-08-01 |
| Empirical Antifungal Treatment in ICUS (NCT01773876) | University Hospital, Grenoble | 2012-07-01 |
| Anidulafungin Pharmacokinetics in Intensive Care Unit Patients (NCT01438216) | Amsterdam UMC, location VUmc | 2011-09-01 |
| Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067) (NCT01045798) | Merck Sharp & Dohme LLC | 2010-12-01 |
| Pharmacokinetics of Anidulafungin on Intensive Care Unit (ICU) (NCT01047267) | University Medical Center Groningen | 2010-06-01 |
| Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen? (NCT00786903) | Robert Krause, MD | 2008-11-01 |
| Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins (NCT01213823) | Pfizer | 2008-09-01 |
| β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients (NCT00672841) | Duke University | 2008-06-01 |
| This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis (NCT00548262) | Pfizer | 2008-02-01 |
| Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug (NCT00608335) | Astellas Pharma Inc | 2007-10-14 |
| Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug (NCT00607763) | Astellas Pharma Inc | 2007-10-01 |
| Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) (NCT00520234) | Mycoses Study Group | 2007-08-01 |
| A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED) (NCT00250432) | Merck Sharp & Dohme LLC | 2006-01-01 |
| Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia (NCT00189709) | Astellas Pharma Inc | 2004-08-01 |